Sector portfolio · VC firm · United States
Menlo Ventures' Biotech portfolio
Menlo Ventures has backed 11 Biotech startups in rounds we track, $1.7B between them, shown by the stage each has reached. The best-funded is Encoded Therapeutics.
Funding by segment
- Series C and later$1.1B5
- Stage not reported$52M2
- Series A$51M2
- Series B$519M2
Where they are based
- United States11$1.7B
United StatesFounded
Total raised
- Under $1M0
- $1M to $10M0
- $10M to $50M5
- $50M to $250M3
- $250M to $1B3
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
11 of 11 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States11
Startups by country, 1 country in all.
Segment by segment
Series C and later
5 startups · $1.1B raised
Encoded TherapeuticsEncoded Therapeutics is a Harnessing the regulatory genome to create next-generation molecular therapies.United States$379M
Recursion PharmaceuticalsRecursion Pharmaceuticals is a biotech company that develops a drug discovery platform and pipeline with machine learning.United States$339M
Sidecar HealthSidecar Health, Inc.United States$183M
BenchlingBenchling is a cloud-based platform for biotechnology research and development and the only biology-first platform for scientific United States$162M- CSComprehend SystemsComprehend provides a suite of cloud applications and consulting services that improve the clinical trial process.United States$46M
Stage not reported
2 startups · $52M raised
Scribe TherapeuticsScribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR molecules.United States$33M
Cofactor GenomicsCofactor Genomics builds multidimensional models of disease to deliver true precision medicine.United States$20M
Series A
2 startups · $51M raised
Series B
2 startups · $519M raised
Pliant TherapeuticsPliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.United States$350M
Senti BiosciencesSenti Biosciences is a biotechnology company that focuses on synthetic biology and gene circuit engineering for therapeutic applications.United States$169M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Menlo Ventures as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like Menlo Ventures?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.